Rosalind holds 9.99% Myomo (MYO) stake plus blocked warrants

Rhea-AI Filing Summary

Myomo, Inc. received an amended Schedule 13G from investment firm Rosalind Advisors, Inc., its fund Rosalind Master Fund L.P., and principals Steven Salamon and Gilad Aharon. They report beneficial ownership of 3,839,772 Myomo common shares, or about 9.99%, based on 38,435,524 shares outstanding as of November 3, 2025.

The group also holds pre-funded warrants for an additional 3,763,258 shares, but a 9.99% ownership blocker prevents exercising these warrants while their stake is at that level. The filers state the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Myomo.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 11)

MYOMO, INC.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

62857J201

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 62857J201

1

Names of Reporting Persons

Rosalind Advisors, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,603,030.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,603,030.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,603,030.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: The percentage set forth in Row 11 of the cover page for each Reporting Person is based upon 38,435,524 shares of the Issuer's common stock outstanding as of November 3rd, 2025, in accordance with the 10Q filed by the issuer on November 10th. However, as more fully described in Item 4, the securities reported in rows (6), (8), and (9) show the number of shares of Common Stock that would be issuable upon exercise of such reported securities and do not give effect to blocker provisions. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows (6), (8), and (9). (6) 3,839,772 shares of Common Stock 3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants

SCHEDULE 13G

CUSIP No. 62857J201

1

Names of Reporting Persons

SALAMON STEVEN A J

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,603,030.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,603,030.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,603,030.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: (6) 3,839,772 shares of Common Stock 3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants

SCHEDULE 13G

CUSIP No. 62857J201

1

Names of Reporting Persons

Aharon Gil

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,603,030.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,603,030.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,603,030.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: (6) 3,839,772 shares of Common Stock 3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants

SCHEDULE 13G

CUSIP No. 62857J201

1

Names of Reporting Persons

Rosalind Master Fund L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,603,030.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,603,030.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,603,030.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: (6) 3,839,772 shares of Common Stock 3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MYOMO, INC.
(b)	Address of issuer's principal executive offices: 137 PORTLAND STREET, 137 PORTLAND STREET, BOSTON, MASSACHUSETTS, 02114
Item 2.
(a)	Name of person filing: Name of Person Filing Rosalind Advisors, Inc. (?Advisor? to RMF) Rosalind Master Fund L.P. (?RMF?) Steven Salamon (?President?) Steven Salamon is the portfolio manager of the Advisor which advises RMF.
(b)	Address or principal business office or, if none, residence: Address of the Principal Office or, if none, residence Rosalind Advisors, Inc. 15 Wellesley Street West, Suite 326 Toronto, Ontario M4Y 0G7 Canada Rosalind Master Fund L.P. P.O. Box 309 Ugland House, Grand Cayman KY1-1104, Cayman Islands Steven Salamon 15 Wellesley Street West, Suite 326 Toronto, Ontario M4Y 0G7 Canada Gilad Aharon 15 Wellesley Street West, Suite 326 Toronto, Ontario M4Y 0G7 Canada
(c)	Citizenship: Rosalind Advisors, Inc.: Ontario, Canada Rosalind Master Fund L.P.: Cayman Islands Steven Salamon: Ontario, Canada Gilad Aharon: Ontario, Canada
(d)	Title of class of securities: Common Shares
(e)	CUSIP No.: 62857J201
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information as of the date of the event which requires filing of this statement required by Items 4(a) to (c) is set forth in Rows 5 to 12 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentage set forth in Row 11 of the cover page for each Reporting Person is based upon 38,435,524 shares of the Issuer's common stock outstanding as of November 3rd, 2025, in accordance with the 10Q filed by the issuer on November 10th , 2025, in accordance with information provided by the issuer. Rosalind Master Fund L.P. may have been deemed to have the beneficial ownership of 3,839,772 shares of common stock representing the beneficial ownership of approximately 9.99% of the common stocks as mentioned above, which excludes the 3,763,258 shares issuable upon the exercise of pre-funded warrants because they contain a blocker provision under which the holder thereof does not have the right to exercise any of the warrant to the extent that such exercise would result in beneficial ownership by the holder in excess of 9.99% of the Common Stock. Consequently, as of the date of the event which requires the filing of this statement, the Reporting Persons were not able to exercise any of the warrants due to the Blockers. Rosalind Advisors, Inc. is the investment advisor to RMF and may be deemed to be the beneficial owner of shares held by RMF. Steven Salamon is the portfolio manager of the Advisor and may be deemed to be the beneficial owner of shares held by RMF. Notwithstanding the foregoing, the Advisor and Mr. Salamon disclaim beneficial ownership of the shares.
(b)	Percent of class: Rosalind Advisors, Inc. - 9.99% Rosalind Master Fund L.P. - 9.99% Steven Salamon - 9.99% Gilad Aharon - 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: Rosalind Advisors, Inc. - 3,839,772 shares of Common Stock Rosalind Master Fund L.P. - 3,839,772 shares of Common Stock Steven Salamon - 3,839,772 shares of Common Stock Gilad Aharon - 3,839,772 shares of Common Stock
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: Rosalind Advisors, Inc. - 3,839,772 shares of Common Stock Rosalind Master Fund L.P. - 3,839,772 shares of Common Stock Steven Salamon - 3,839,772 shares of Common Stock Gilad Aharon - 3,839,772 shares of Common Stock
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Rosalind Advisors, Inc.

Signature:	Steven Salamon
Name/Title:	President
Date:	02/11/2026

SALAMON STEVEN A J

Signature:	Steven Salamon
Name/Title:	Steven Salamon
Date:	02/11/2026

Aharon Gil

Signature:	Gil Aharon
Name/Title:	Gil Aharon
Date:	02/11/2026

Rosalind Master Fund L.P.

Signature:	Mike McDonald
Name/Title:	Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:	02/11/2026

FAQ

What ownership stake does Rosalind report in Myomo (MYO)?

Rosalind and related reporting persons disclose beneficial ownership of 3,839,772 Myomo common shares, representing about 9.99% of the company, based on 38,435,524 shares outstanding as of November 3, 2025, according to Myomo’s Form 10-Q.

What additional Myomo securities does Rosalind hold beyond common shares?

In addition to common shares, the reporting persons hold pre-funded warrants for 3,763,258 Myomo shares. These warrants are currently constrained by a 9.99% ownership blocker, which means they cannot be exercised if doing so would push ownership above that threshold.

Who are the reporting persons on this Myomo (MYO) Schedule 13G/A?

The reporting persons are Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon. Rosalind Advisors acts as investment adviser to the fund, and Salamon is its portfolio manager; they may be deemed beneficial owners of shares held by the fund.

How is the 9.99% Myomo ownership calculated for Rosalind?

The reported 9.99% stake is calculated using 38,435,524 Myomo common shares outstanding as of November 3, 2025, as disclosed in Myomo’s Form 10-Q filed November 10, 2025. The percentage reflects 3,839,772 shares held, excluding warrant shares blocked from exercise.

What is the purpose of the 9.99% blocker on Rosalind’s Myomo warrants?

The pre-funded warrants include a 9.99% ownership blocker, which prevents the holders from exercising any warrant portion that would raise their beneficial ownership above 9.99% of Myomo’s common stock. As of the reporting date, this blocker means the warrants cannot be exercised.

Does Rosalind seek to influence control of Myomo (MYO) with this stake?

The reporting persons certify the securities were acquired and are held in the ordinary course of business, and not for the purpose or effect of changing or influencing control of Myomo, nor in connection with any transaction intended to achieve that purpose.